English
SpanishTrusted Resources: Community Center
Online groups, photo galleries and blogs
Patient of the Month: Gianna
After noticing that her daughter was unable to crawl, stand, or do the things her friend’s children were doing at six months of age, Idalmis decided that it was time to seek help. Sure enough, after some consultations and genetic testing, Idalmis’ gut feeling was right.
Her baby girl, Gianna, was diagnosed with spinal muscular atrophy type 2 (SMA2), a genetic neuromuscular disorder that affects the nerve cells that control voluntary muscles (motor neurons). Without treatment, progressive muscle weakness develops in babies with SMA2 between ages 6 and 12 months.
BookmarkRelated Content
-
Spinal Muscular Atrophy Type 2 (Intermediate SMA)Spinal muscular atrophy (SMA) is a genet...
-
Improvement in Fine Manual Dexterity in Children With Spinal Muscular Atrophy Type 2 After Nusinersen Injection: A C...Although nusinersen has been demonstrate...
-
Spinal Muscular Atrophy (SMA)Spinal muscular atrophy (SMA) is a genet...
-
Lunch & Learn: Gene Therapy for SMAhttps://www.youtube.com/watch?v=YFEMR1ZH...
-
Expert Recommendations and Clinical Considerations in the Use of Onasemnogene Abeparvovec Gene Therapy for Spinal Mu...Spinal muscular atrophy (SMA) is an auto...
-
Once-Daily Risdiplam Beneficial in Patients With Types 2 and 3 SMA: LancetOnce-Daily Risdiplam is beneficial in pa...
-
Let’s Start From the BeginningScarlet was born at 40 weeks and 1 day. ...
